Establishment of Acenocoumarol Pharmacogenetic Algorithm Including CYP2C9 and VKORC1 Genotypes in Bulgarian Patients Treated with Coumarin Anticoagulants

Acenocoumarol, a 4-hydroxycoumarin derivative, is widely prescribed for the primary and secondary prevention of thromboembolic disorders. Maintenance dosing of acenocoumarol is significantly influenced by polymorphic variants in the CYP2C9 and VKORC1 genes. Other critical factors affecting dosing in...

Full description

Saved in:
Bibliographic Details
Main Authors: Tzveova R., Saraeva R., Dimitrova-Karamfilova A., Nachev G., Mitev V., Kaneva R., Pendicheva-Duhlenska D.
Format: Article
Language:English
Published: Sciendo 2025-06-01
Series:Acta Medica Bulgarica
Subjects:
Online Access:https://doi.org/10.2478/amb-2025-0039
Tags: Add Tag
No Tags, Be the first to tag this record!